Filtering by:
Multiple MyelomaStudy: Getting Enough Exercise Lowers Risk of 7 Cancers
Getting recommended amounts of physical activity is linked to a lower risk for 7 cancer types, according to a study from the American Cancer Society, the National Cancer Institute, and the Harvard T.H. Chan School of Public Health.
Study: Millennials’ Increased Risk for Some Obesity-Linked Cancers — 5 Takeaways
Researchers at the American Cancer Society found that 6 cancers proven to be related to obesity are increasing more rapidly in people younger than 50 than those older than 50. To understand what this study means to you and your loved ones, read these 5 key takeaway messages.
Studies Examine Possible Cancer Risks for Firefighters at World Trade Center
Two studies examine whether exposure to chemicals from the wreckage of the World Trade Center during rescue and recovery work after the September 11, 2001 attacks increased firefighters’ risk of developing cancer.
25-Year Multiple Myeloma Survivor Rides for Hope
Multiple myeloma survivor Jim Bond is easy to spot among the hundreds of bicyclists in the Pan Ohio Hope Ride, which takes place every July and raises money for the American Cancer Society.
World Health Organization Links 8 More Cancer Types to Excess Weight
The International Agency for Research on Cancer (IARC), part of the World Health Organization, has added 8 types of cancer to those it had previously linked to being overweight or obese.
Survivor Speaks Out about Life After Multiple Myeloma
It was a weekend in November 2013 that started on a celebratory note when Matt Blennau and his wife, Carolyn, took their 3 kids to dinner. They were celebrating their son’s fifth birthday.
Experts Gather for Annual Meeting on Blood Diseases
More than 25,000 hematology specialists from all over the world are in Orlando, Florida this week for the annual meeting of the American Society of Hematology (ASH).
FDA Approves Ninlaro (Ixazomib) for Multiple Myeloma
The US Food and Drug Administration (FDA) has approved the third drug this year for treating multiple myeloma, a type of cancer that starts in plasma cells.